Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 195

1.

The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease.

Berdichevski T, Keller N, Rahav G, Bar-Meir S, Eliakim R, Ben-Horin S.

Infection. 2013 Oct;41(5):969-77. doi: 10.1007/s15010-013-0473-4. Epub 2013 May 26.

PMID:
23709307
2.

Diverticulitis in the young is not more aggressive than in the elderly, but it tends to recur more often: systematic review and meta-analysis.

Katz LH, Guy DD, Lahat A, Gafter-Gvili A, Bar-Meir S.

J Gastroenterol Hepatol. 2013 Aug;28(8):1274-81. doi: 10.1111/jgh.12274. Review.

PMID:
23701446
3.

Mucosal improvement in patients with moderate to severe postoperative endoscopic recurrence of Crohn's disease and azathioprine metabolite levels.

Angelberger S, Schaeffeler E, Teml A, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR, Schwab M, Reinisch W.

Inflamm Bowel Dis. 2013 Mar;19(3):590-8. doi: 10.1097/MIB.0b013e31827eea8b.

PMID:
23388543
4.

Role of endoscopy in patients with diverticular disease.

Bar-Meir S, Lahat A, Melzer E.

Dig Dis. 2012;30(1):60-3. doi: 10.1159/000335921. Epub 2012 May 3. Review.

PMID:
22572687
5.

The risk of advanced histology in small-sized colonic polyps: are non-invasive colonic imaging modalities good enough?

Shapiro R, Ben-Horin S, Bar-Meir S, Avidan B.

Int J Colorectal Dis. 2012 Aug;27(8):1071-5. Epub 2012 Feb 2.

PMID:
22297863
6.

Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.

Prantera C, Lochs H, Grimaldi M, Danese S, Scribano ML, Gionchetti P; Retic Study Group (Rifaximin-Eir Treatment in Crohn's Disease)..

Gastroenterology. 2012 Mar;142(3):473-481.e4. doi: 10.1053/j.gastro.2011.11.032. Epub 2011 Dec 6.

PMID:
22155172
7.

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis.

Kruis W, Jonaitis L, Pokrotnieks J, Mikhailova TL, Horynski M, Bátovský M, Lozynsky YS, Zakharash Y, Rácz I, Kull K, Vcev A, Faszczyk M, Dilger K, Greinwald R, Mueller R; International Salofalk OD Study Group..

Aliment Pharmacol Ther. 2011 Feb;33(3):313-22. doi: 10.1111/j.1365-2036.2010.04537.x. Epub 2010 Dec 8.

8.

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.

Tromm A, Bunganič I, Tomsová E, Tulassay Z, Lukáš M, Kykal J, Bátovský M, Fixa B, Gabalec L, Safadi R, Kramm HJ, Altorjay I, Löhr H, Koutroubakis I, Bar-Meir S, Stimac D, Schäffeler E, Glasmacher C, Dilger K, Mohrbacher R, Greinwald R; International Budenofalk Study Group..

Gastroenterology. 2011 Feb;140(2):425-434.e1; quiz e13-4. doi: 10.1053/j.gastro.2010.11.004. Epub 2010 Nov 9.

PMID:
21070781
9.

Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response.

Buti M, Lurie Y, Zakharova NG, Blokhina NP, Horban A, Teuber G, Sarrazin C, Balciuniene L, Feinman SV, Faruqi R, Pedicone LD, Esteban R; SUCCESS Study Investigators..

Hepatology. 2010 Oct;52(4):1201-7. doi: 10.1002/hep.23816.

PMID:
20683847
10.

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.

Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D; Semapimod-CD04/CD05 Investigators..

Gut. 2010 Jun;59(6):760-6. doi: 10.1136/gut.2009.179994.

PMID:
20551461
11.

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group..

Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159.

PMID:
20551460
12.

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful.

Ben-Horin S, Yavzori M, Katz L, Kopylov U, Picard O, Fudim E, Coscas D, Bar-Meir S, Goldstein I, Chowers Y.

Gut. 2011 Jan;60(1):41-8. doi: 10.1136/gut.2009.201533. Epub 2010 Jun 2.

PMID:
20519742
13.

Pseudomembranes in a patient with flare-up of inflammatory bowel disease (IBD): is it only Clostridium difficile or is it still an IBD exacerbation?

Berdichevski T, Barshack I, Bar-Meir S, Ben-Horin S.

Endoscopy. 2010;42 Suppl 2:E131. doi: 10.1055/s-0029-1244045. Epub 2010 Apr 19. No abstract available.

PMID:
20405379
14.

Long-term clinical outcome of patients with gastric gastrointestinal stromal tumors.

Maor Y, Avidan B, Melzer E, Bar-Meir S.

Dig Dis Sci. 2010 Oct;55(10):2893-8. doi: 10.1007/s10620-009-1107-7. Epub 2010 Jan 27.

PMID:
20108039
15.

Double balloon enteroscopy: a 2 year experience.

Lahat A, Nadler M, Simon C, Lahav M, Novis B, Bar-Meir S.

Isr Med Assoc J. 2009 Aug;11(8):456-9.

16.

Mild to moderate Crohn's disease: still room for step-up therapies?

Bar-Meir S.

Dig Dis. 2009;27(3):347-50. doi: 10.1159/000228572. Epub 2009 Sep 24. Review.

PMID:
19786763
17.

Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role.

Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y.

Ann N Y Acad Sci. 2009 Sep;1173:640-8. doi: 10.1111/j.1749-6632.2009.04673.x.

PMID:
19758210
18.

Fibrotest or Fibroscan for evaluation of liver fibrosis in haemophilia patients infected with hepatitis C.

Maor Y, Halfon P, Bashari D, Pénaranda G, Morali G, Klar R, Bar-Meir S, Martinowitz U, Oren R.

Haemophilia. 2010 Jan;16(1):148-54. doi: 10.1111/j.1365-2516.2009.02092.x. Epub 2009 Sep 4.

PMID:
19702631
19.

A new rectal ultrasonographic method for the staging of rectal cancer.

Beer-Gabel M, Assouline Y, Zmora O, Venturero M, Bar-Meir S, Avidan B.

Dis Colon Rectum. 2009 Aug;52(8):1475-80. doi: 10.1007/DCR.0b013e3181a7b69d.

PMID:
19617763
20.

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.

Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M, Bouhnik Y, Seidman E, Keuchel M, Albert JG, Ardizzone S, Bar-Meir S, Bisschops R, Despott EJ, Fortun PF, Heuschkel R, Kammermeier J, Leighton JA, Mantzaris GJ, Moussata D, Lo S, Paulsen V, Panés J, Radford-Smith G, Reinisch W, Rondonotti E, Sanders DS, Swoger JM, Yamamoto H, Travis S, Colombel JF, Van Gossum A; World Organisation of Digestive Endoscopy (OMED) and the European Crohn's and Colitis Organisation (ECCO)..

Endoscopy. 2009 Jul;41(7):618-37. doi: 10.1055/s-0029-1214790. Epub 2009 Jul 8. Review.

PMID:
19588292

Supplemental Content

Loading ...
Support Center